Share this
how to make patient monitoring smarter, simpler, and more specific
by Neoteryx Microsampling on Jan 28, 2019 6:09:00 AM
Technology is taking much of the guesswork out of medicine. Innovations in patient monitoring and data collection now allow doctors and other healthcare professionals to track patients' conditions over time, sometimes without even requiring in-person visits.
Anyone interested in the biggest questions around human health and flourishing - how we live, how we care for each other, and how these systems can be improved - should be acutely aware of new progress in patient monitoring, particularly remote patient monitoring (RPM), as healthcare grows increasingly decentralized, democratized, and intelligent.
Remote sampling - the collection small, precise volumes of blood or other biological fluid using microsampling devices - is a crucial part of this story. Thanks to advances in technology, it is now possible to get a tremendous amount of information from a very small amount of biological material. Collecting that material in the precise volumes needed, at a reasonable cost and convenience, has heretofore posed a challenge.
Now, the Mitra® microsampling device, powered by Volumetric Absorptive Microsampling (VAMS™) technology, provides the missing link between the ideas, the innovations, and the stuff of human life.
With microsampling, it is less and less important that patients visit clinics to receive optimum care. More and more, they can receive it in the comfort of their homes or elsewhere, by taking and shipping their own samples and consulting with well-informed medical professionals through Skype, Google Hangouts, for FaceTime.
Thus, microsampling helps enable constant medical supervision without the inconvenience of constant in-person appointments. It allows healthcare professionals to get more information at more appropriate times, for more useful insights, without unreasonable costs or additional burden on patients' bandwidth.
Mitra devices build new bridges between software, lab testing services, and patients, including aging or immobilized patients and those with chronic conditions.
Much success in microsampling has already been achieved in the realms of therapeutic drug monitoring and other long-term treatments.
- It eliminates the hematocrit (HCT) bias that reduced the effectiveness and slowed the adoption of earlier small-volume dried blood collection methods, generating results comparable to those from the wet blood gold standard.
- It’s been validated for at-home HbA1c monitoring for pediatric patients with diabetes.
- And it works similar magic for immunosuppressants, antiepileptics, antipsychotics, and other vital and serious long-term drug regimens.
- It's also used in substance abuse recovery and other situations where needles aren't the most appropriate solution
Microsampling improves patient comfort and convenience versus other methods, particularly painful venipuncture. What’s more, with the money saved on transportation, clinic visits, and other costs associated with traditional methods, switching to a microsampling workflow for patient monitoring can save considerable sums of money over time.
And the future looks even more promising. From the strength of the results already achieved, VAMS is poised to enable further innovations in booming areas such as:
- Precision medicine – facilitating more precise, tailored regimens of care, using patient-centered models
- Predictive care - anticipating, say, a cardiac event, before it occurs, allowing plenty of time for the right intervention
- Consumer health and wellness - allowing fitness fans and nutrition buffs to monitor their own biomarkers in real time
- Aging in place - encouraging markedly better quality of life, despite medical challenges, well into the golden years
If you’re invested in the growth, the development, and the future of patient monitoring, now is the best time to explore microsampling.
Right now, businesses and institutions are evaluating, validating, and implementing this breakthrough technology. Investors and innovators are picturing how it fits into their existing or proposed solutions. And patients are improving their lives, taking greater agency over their treatment, and staying closer to their families and communities in times of turbulence and uncertainty.
The future of patient monitoring is already in progress, and it all depends on a small, absurdly simple blood collection device. It’s time to join the microsampling revolution.
Share this
- Microsampling (186)
- Venipuncture Alternative (108)
- Research, Remote Research (88)
- Clinical Trials, Clinical Research (82)
- Mitra® Device (71)
- Therapeutic Drug Monitoring, TDM (48)
- Dried Blood Spot, DBS (37)
- Biomonitoring, Health, Wellness (35)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (15)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (11)
- Pharmaceuticals, Drug Development (8)
- Harpera® Tool (5)
- Skin Microsampling, Microbiopsy (5)
- Company Press Release, Product Press Release (4)
- Industry News, Microsampling News (4)
- Antibodies, MAbs (3)
- September 2023 (2)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (3)
- September 2019 (4)
- August 2019 (5)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (7)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think